Child'parent familial hypercholesterolemia screening in primary care

New England Journal of Medicine

Volumn 375, Issue 17, 2016, Pages 1628-1637

  Wald, David S ^a   Bestwick, Jonathan P ^a   Morris, Joan K ^a   Whyte, Ken ^a   Jenkins, Lucy ^b   Wald, Nicholas J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL;

ADULT; ARTICLE; CAPILLARY BLOOD; CARDIOVASCULAR DISEASE; CHILD; CHILD PARENT RELATION; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MASS SCREENING; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM; BLOOD; GENETICS; HYPERLIPOPROTEINEMIA TYPE II; INFANT; MUTATION; PARENT; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE;

ADULT; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFANT; MALE; MASS SCREENING; MUTATION; PARENTS; PREVENTIVE HEALTH SERVICES; PRIMARY HEALTH CARE;

EID: 84992726174     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1602777     Document Type: Article

References (27)

1. Wald DS, Bestwick JP, Wald NJ. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-Analysis. BMJ 2007; 335: 599.
2. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 1991; 303: 893-6.
3. Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004; 292: 331-7.
4. Gidding SS, Champagne MA, de Ferranti SD, et al. The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association. Circulation 2015; 132: 2167-92.
5. DeMott K, Nherera L, Shaw EJ, et al. Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2008.
6. Fouchier SW, Hutten BA, Defesche JC. Current novel-gene-finding strategy for autosomal-dominant hypercholesterolaemia needs refinement. J Med Genet 2015; 52: 80-4.
7. Huijgen R, Hutten BA, Kindt I, Vissers MN, Kastelein JJ. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a crosssectional study in 26,406 individuals tested for genetic FH. Circ Cardiovasc Genet 2012; 5: 354-9.
8. Slimane MN, Lestavel S, Sun X-M, et al. Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families. Atherosclerosis 2001; 154: 557-65.
9. Jelassi A, Slimani A, Jguirim I, et al. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia. Clin Chim Acta 2010; 411: 735-8.
10. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34: 3478-90a.
11. Wald DS, Kasturiratne A, Godoy A, et al. Child-parent screening for familial hypercholesterolemia. J Pediatr 2011; 159: 865-7.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
13. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003; 10: 56-104.
14. Leigh SE, Foster AH, Whittall RA, Hubbart CS, Humphries SE. Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet 2008; 72: 485-98.
15. Mori T, Iwaki Y, Hando R, et al. QuickGene Series: Rapid and simple system for DNA/RNA extraction which uses polymer porous membrane. Japan J Clin Chem 2007; 36: 33-9.
16. Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 2012; 97: 3956-64.
17. Sun X-M, Patel DD, Webb JC, et al. Familial hypercholesterolemia in China: identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler Thromb 1994; 14: 85-94.
18. Klancar G, Grošelj U, Kovac J, et al. Universal screening for familial hypercholesterolemia in children. J Am Coll Cardiol 2015; 66: 1250-7.
19. Wang J, Huff E, Janecka L, Hegele RA. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent. Hum Mutat 2001; 18: 359.
20. Taylor A, Tabrah S, Wang D, et al. Multiplex ARMS analysis to detect 13 common mutations in familial hypercholesterolaemia. Clin Genet 2007; 71: 561-8.
21. Day INM, Whittall RA, O'Dell SD, et al. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Hum Mutat 1997; 10: 116-27.
22. Varret M, Abifadel M, Rabés JP, Boileau C. Genetic heterogeneity of autosomal dominant hypercholesterolemia. Clin Genet 2008; 73: 1-13.
23. Goldberg AC, Hopkins PN, Toth PP, et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011; 5: 133-40.
24. Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? BMJ 1999; 319: 1562-5.
25. Petrucelli N, Daly MB, Feldman GL. BRCA1 and BRCA2 hereditary breast and ovarian cancer. In: Pagon RA, Adam MP, Ardinger HH, et al., eds. GeneReviews. Seattle: University of Washington, September 4, 1998 (updated September 26, 2013).
26. Wald NJ, Bestwick JP. Performance of antenatal reflex DNA screening for Down's syndrome. J Med Screen 2015; 22: 168-74.
27. Wald NJ, Huttly WJ, Bestwick JP, Aquilina J, Peregrine E. Reflex antenatal DNA screening for Down syndrome. Prenat Diagn 2015; 35: 1154.